MARCUS JOEL S — SEC insider filings
SEC reporting owner CIK 1216955. 74 insider filings on record with FilingPulse; latest filed 2026-10-13.
Transaction summary — filings shown
Covers the 50 most recent of 74 filings on record, filed 2022-04-04 to 2026-10-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 10 legs across 6 filings — 60,000 shares, $2,905,863 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 13 legs across 10 filings — 94,328 shares, $8,402,976 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 72.
- Largest priced transaction: sale of 9,000 shares @ $168.00 ($1,512,000) in ALEXANDRIA REAL ESTATE EQUITIES, INC., filed 2023-02-09.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ALEXANDRIA REAL ESTATE EQUITIES, INC. (ARE) | Executive Chairman, Director | 26 | 10 legs · 60,000 sh · $2,905,863 | 5 legs · 33,000 sh · $4,675,400 | 19 |
| Intra-Cellular Therapies, Inc. (ITCI) | Director | 11 | — | 8 legs · 61,328 sh · $3,727,576 | 19 |
| Applied Therapeutics, Inc. (APLT) | Director | 7 | — | — | 24 |
| Frequency Therapeutics, Inc. (FREQ) | Director | 2 | — | — | 5 |
| TRex Bio, Inc. (TRXB) | Director | 3 | — | — | 3 |
| MeiraGTx Holdings plc (MGTX) | Director | 1 | — | — | 2 |
Insider filings — MARCUS JOEL S
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-13 | 4 | TRex Bio, Inc. (TRXB) | Conversion (C): 41,871 · Conversion (C): 161,828 (derivative) @ $0 | EDGAR |
| 2026-10-08 | 3 | TRex Bio, Inc. (TRXB) | Holdings only — no transactions reported | EDGAR |
| 2026-10-08 | 4 | TRex Bio, Inc. (TRXB) | Grant/award (A): 17,500 (derivative) @ $0 | EDGAR |
| 2026-09-15 | 4 | ALEXANDRIA REAL ESTATE EQUITIES, INC. (ARE) | Purchase (P): 5,000 @ $49.68 | EDGAR |
| 2026-08-19 | 4 | ALEXANDRIA REAL ESTATE EQUITIES, INC. (ARE) | Purchase (P): 5,000 @ $46.28 | EDGAR |
| 2026-05-07 | 4 | ALEXANDRIA REAL ESTATE EQUITIES, INC. (ARE) | Purchase (P): 3,989 @ $45.99 · Purchase (P): 3,511 @ $46.74 | EDGAR |
| 2026-05-06 | 4 | ALEXANDRIA REAL ESTATE EQUITIES, INC. (ARE) | Purchase (P): 2,062 @ $41.89 · Purchase (P): 3,832 @ $42.76 · Purchase (P): 1,606 @ $43.70 | EDGAR |
| 2026-05-05 | 4 | ALEXANDRIA REAL ESTATE EQUITIES, INC. (ARE) | Purchase (P): 10,000 @ $41.02 | EDGAR |
| 2026-02-13 | 4 | ALEXANDRIA REAL ESTATE EQUITIES, INC. (ARE) | Purchase (P): 17,300 @ $53.74 · Purchase (P): 7,700 @ $54.31 | EDGAR |
| 2026-01-26 | 4 | ALEXANDRIA REAL ESTATE EQUITIES, INC. (ARE) | Disposition to issuer (D): 14,671 @ $0 · Disposition to issuer (D): 35,075 @ $0 | EDGAR |
| 2026-01-13 | 4 | ALEXANDRIA REAL ESTATE EQUITIES, INC. (ARE) | Grant/award (A): 100,056 @ $0 | EDGAR |
| 2026-01-05 | 4 | ALEXANDRIA REAL ESTATE EQUITIES, INC. (ARE) | Grant/award (A): 31,270 @ $0 | EDGAR |
| 2025-04-02 | 4 | Intra-Cellular Therapies, Inc. (ITCI) | Disposition to issuer (D): 48,238 @ $132 · Disposition to issuer (D): 10,000 @ $132 · Disposition to issuer (D): 4,322 (derivative) · Disposition to issuer (D): 2,951 (derivative) | EDGAR |
| 2025-02-26 | 4 | Intra-Cellular Therapies, Inc. (ITCI) | Option exercise (M): 7,009 @ $63.79 · Option exercise (M): 7,009 (derivative) @ $0 | EDGAR |
| 2025-01-14 | 4 | ALEXANDRIA REAL ESTATE EQUITIES, INC. (ARE) | Grant/award (A): 46,207 @ $0 | EDGAR |
| 2025-01-03 | 4 | ALEXANDRIA REAL ESTATE EQUITIES, INC. (ARE) | Disposition to issuer (D): 19,156 @ $0 · Grant/award (A): 15,610 @ $0 | EDGAR |
| 2024-06-25 | 4 | Intra-Cellular Therapies, Inc. (ITCI) | Option exercise (M): 1,567 · Option exercise (M): 1,567 (derivative) @ $0 | EDGAR |
| 2024-06-18 | 4 | Intra-Cellular Therapies, Inc. (ITCI) | Grant/award (A): 2,951 (derivative) @ $0 · Grant/award (A): 4,322 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | Applied Therapeutics, Inc. (APLT) | Grant/award (A): 45,000 @ $0 | EDGAR |
| 2024-04-02 | 4 | ALEXANDRIA REAL ESTATE EQUITIES, INC. (ARE) | Disposition to issuer (D): 10,655 @ $0 · Tax withholding (F): 5,400 @ $128.91 | EDGAR |
| 2024-02-28 | 4 | ALEXANDRIA REAL ESTATE EQUITIES, INC. (ARE) | Sale (S): 7,500 @ $118.92 | EDGAR |
| 2024-02-27 | 4 | Intra-Cellular Therapies, Inc. (ITCI) | Option exercise (M): 20,000 @ $43.45 · Option exercise (M): 16,757 @ $55.48 · Sale (S): 8,371 @ $67.83 · Sale (S): 17,658 @ $69.07 · Sale (S): 299 @ $69.60 · Option exercise (M): 20,000 (derivative) @ $0 · +1 more | EDGAR |
| 2024-01-12 | 4 | ALEXANDRIA REAL ESTATE EQUITIES, INC. (ARE) | Grant/award (A): 35,064 @ $0 | EDGAR |
| 2024-01-09 | 4 | ALEXANDRIA REAL ESTATE EQUITIES, INC. (ARE) | Grant/award (A): 3,000 @ $0 | EDGAR |
| 2024-01-04 | 4 | ALEXANDRIA REAL ESTATE EQUITIES, INC. (ARE) | Grant/award (A): 47,620 @ $0 | EDGAR |
| 2023-09-19 | 4 | Applied Therapeutics Inc. (APLT) | Option exercise (M): 12,375 @ $1.05 · Option exercise (M): 12,375 (derivative) @ $0 | EDGAR |
| 2023-06-27 | 4 | Intra-Cellular Therapies, Inc. (ITCI) | Grant/award (A): 1,567 (derivative) @ $0 · Grant/award (A): 7,009 (derivative) @ $0 | EDGAR |
| 2023-06-08 | 4 | Applied Therapeutics Inc. (APLT) | Grant/award (A): 20,000 @ $0 | EDGAR |
| 2023-05-10 | 4 | ALEXANDRIA REAL ESTATE EQUITIES, INC. (ARE) | Sale (S): 7,500 @ $122.20 | EDGAR |
| 2023-04-04 | 4 | ALEXANDRIA REAL ESTATE EQUITIES, INC. (ARE) | Disposition to issuer (D): 6,507 @ $0 · Tax withholding (F): 10,015 @ $125.59 | EDGAR |
| 2023-02-09 | 4 | ALEXANDRIA REAL ESTATE EQUITIES, INC. (ARE) | Sale (S): 9,000 @ $168 | EDGAR |
| 2023-01-31 | 4 | ALEXANDRIA REAL ESTATE EQUITIES, INC. (ARE) | Tax withholding (F): 5,608 @ $160.68 | EDGAR |
| 2023-01-12 | 4 | ALEXANDRIA REAL ESTATE EQUITIES, INC. (ARE) | Grant/award (A): 24,051 @ $0 | EDGAR |
| 2023-01-05 | 4 | ALEXANDRIA REAL ESTATE EQUITIES, INC. (ARE) | Grant/award (A): 42,260 @ $0 | EDGAR |
| 2022-12-21 | 4 | Intra-Cellular Therapies, Inc. (ITCI) | Sale (S): 5,000 @ $50.82 | EDGAR |
| 2022-12-14 | 4 | ALEXANDRIA REAL ESTATE EQUITIES, INC. (ARE) | Sale (S): 6,500 @ $150 | EDGAR |
| 2022-12-07 | 4 | ALEXANDRIA REAL ESTATE EQUITIES, INC. (ARE) | Sale (S): 2,500 @ $152 | EDGAR |
| 2022-11-08 | 4 | Intra-Cellular Therapies, Inc. (ITCI) | Sale (S): 5,000 @ $52.49 · Sale (S): 5,000 @ $52.11 | EDGAR |
| 2022-09-16 | 4/A | Applied Therapeutics Inc. (APLT) | Option exercise (M): 13,071 @ $10 · Option exercise (M): 35,911 @ $4.70 · Option exercise (M): 13,071 (derivative) @ $0 | EDGAR |
| 2022-09-16 | 4 | Applied Therapeutics Inc. (APLT) | Option exercise (M): 7,389 @ $1.05 · Option exercise (M): 10,230 @ $1.05 · Option exercise (M): 16,500 @ $1.05 · Option exercise (M): 4,125 @ $1.05 · Option exercise (M): 7,389 (derivative) @ $0 · Option exercise (M): 10,230 (derivative) @ $0 · +2 more | EDGAR |
| 2022-08-19 | 4 | Frequency Therapeutics, Inc. (FREQ) | Grant/award (A): 14,846 (derivative) · Disposition to issuer (D): 14,846 (derivative) · Grant/award (A): 14,846 (derivative) · Disposition to issuer (D): 14,846 (derivative) | EDGAR |
| 2022-08-12 | 4 | Intra-Cellular Therapies, Inc. (ITCI) | Sale (S): 10,000 @ $59.22 | EDGAR |
| 2022-08-04 | 4 | Applied Therapeutics Inc. (APLT) | Disposition to issuer (D): 16,500 (derivative) · Disposition to issuer (D): 16,500 (derivative) · Disposition to issuer (D): 16,500 (derivative) · Disposition to issuer (D): 16,500 (derivative) · Disposition to issuer (D): 10,230 (derivative) · Disposition to issuer (D): 10,230 (derivative) · +2 more | EDGAR |
| 2022-06-23 | 4 | Frequency Therapeutics, Inc. (FREQ) | Grant/award (A): 14,846 (derivative) @ $0 | EDGAR |
| 2022-06-13 | 4 | Intra-Cellular Therapies, Inc. (ITCI) | Grant/award (A): 16,757 (derivative) @ $0 | EDGAR |
| 2022-06-09 | 4 | MeiraGTx Holdings plc (MGTX) | Grant/award (A): 15,000 (derivative) @ $0 · Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2022-06-07 | 4 | Applied Therapeutics Inc. (APLT) | Grant/award (A): 16,500 (derivative) @ $0 | EDGAR |
| 2022-05-24 | 4 | ALEXANDRIA REAL ESTATE EQUITIES, INC. (ARE) | Grant/award (A): 2,500 @ $0 | EDGAR |
| 2022-05-13 | 4 | Intra-Cellular Therapies, Inc. (ITCI) | Option exercise (M): 14,189 · Sale (S): 10,000 @ $55 · Option exercise (M): 14,189 (derivative) @ $0 | EDGAR |
| 2022-04-04 | 4 | ALEXANDRIA REAL ESTATE EQUITIES, INC. (ARE) | Grant/award (A): 24,560 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-08-10 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1216955 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs